FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985021708> ?p ?o ?g. }

• W1985021708 endingPage "126" @default.
• W1985021708 startingPage "121" @default.
• W1985021708 abstract "The aim of this study was to investigate the possible protective role of antioxidant treatment with ellagic acid on cisplatin-induced nephrotoxicity using biochemical and histopatological approaches. Adult male Sprague-Dawley rats were randomly divided into four groups. The control group received 0.9% saline; animals in the ellagic acid group received only ellagic acid (10 mg/kg); animals in the cisplatin group received only cisplatin (7 mg/kg); animals in the cisplatin + ellagic acid group received ellagic acid for 10 days after cisplatin. The effects of ellagic acid on cisplatin-induced nephrotoxicity were evaluated by plasma creatinine, urea, sodium and calcium concentrations; kidney tissue malondialdehyde, reduced glutathione (GSH), glutathione peroxidase (GSH peroxidase) and catalase activities and histopatological examinations. Administration of cisplatin to rats induced a marked renal failure, characterized by significant increases in plasma creatinine, urea and calcium concentrations. Cisplatin also induced oxidative stress, as indicated by increased kidney tissue concentrations of malondialdehyde, and reduced activities of GSH peroxidase and catalase. Furthermore, treatment with cisplatin caused a marked tubular necrosis, degeneration and desquamation, luminal cast formation, karyomegaly, tubular dilatation, interstitial mononuclear cell infiltration and inter-tubular haemorrhagia. Ellagic acid markedly reduced elevated plasma creatinine, urea and calcium levels and counteracted the deleterious effects of cisplatin on oxidative stress markers. In the same way, ellagic acid ameliorated cisplatin-induced pathological changes including tubular necrosis, degeneration, karyomegaly, tubular dilatation when compared to the cisplatin alone group. These results indicate that the antioxidant ellagic acid might have a protective effect against cisplatin-induced nephrotoxicity and oxidative stress in rat, but not enough to inhibit cisplatin-induced renal dysfunction." @default.
• W1985021708 created "2016-06-24" @default.
• W1985021708 creator A5006496635 @default.
• W1985021708 creator A5019459457 @default.
• W1985021708 creator A5051207235 @default.
• W1985021708 creator A5051290396 @default.
• W1985021708 creator A5078263280 @default.
• W1985021708 date "2006-12-06" @default.
• W1985021708 modified "2023-10-18" @default.
• W1985021708 title "Role of Ellagic Acid against Cisplatin‐Induced Nephrotoxicity and Oxidative Stress in Rats" @default.
• W1985021708 cites W1493780140 @default.
• W1985021708 cites W1540306958 @default.
• W1985021708 cites W1775749144 @default.
• W1985021708 cites W1968857252 @default.
• W1985021708 cites W1971168416 @default.
• W1985021708 cites W1973899663 @default.
• W1985021708 cites W1975980695 @default.
• W1985021708 cites W1982585224 @default.
• W1985021708 cites W1998553196 @default.
• W1985021708 cites W1998866954 @default.
• W1985021708 cites W1999999237 @default.
• W1985021708 cites W2009845049 @default.
• W1985021708 cites W2013194529 @default.
• W1985021708 cites W2016176618 @default.
• W1985021708 cites W2023773512 @default.
• W1985021708 cites W2024498485 @default.
• W1985021708 cites W2025301375 @default.
• W1985021708 cites W2027756656 @default.
• W1985021708 cites W2031610105 @default.
• W1985021708 cites W2036940703 @default.
• W1985021708 cites W2049995044 @default.
• W1985021708 cites W2056594432 @default.
• W1985021708 cites W2063576996 @default.
• W1985021708 cites W2068933269 @default.
• W1985021708 cites W2072160569 @default.
• W1985021708 cites W2076032177 @default.
• W1985021708 cites W2080622529 @default.
• W1985021708 cites W2082177666 @default.
• W1985021708 cites W2086910295 @default.
• W1985021708 cites W2088608307 @default.
• W1985021708 cites W2090163153 @default.
• W1985021708 cites W2090622910 @default.
• W1985021708 cites W2101571252 @default.
• W1985021708 cites W2107353472 @default.
• W1985021708 cites W2110376874 @default.
• W1985021708 cites W2117319789 @default.
• W1985021708 doi "https://doi.org/10.1111/j.1742-7843.2006.00015.x" @default.
• W1985021708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17244261" @default.
• W1985021708 hasPublicationYear "2006" @default.
• W1985021708 type Work @default.
• W1985021708 sameAs 1985021708 @default.
• W1985021708 citedByCount "46" @default.
• W1985021708 countsByYear W19850217082012 @default.
• W1985021708 countsByYear W19850217082013 @default.
• W1985021708 countsByYear W19850217082014 @default.
• W1985021708 countsByYear W19850217082015 @default.
• W1985021708 countsByYear W19850217082016 @default.
• W1985021708 countsByYear W19850217082017 @default.
• W1985021708 countsByYear W19850217082018 @default.
• W1985021708 countsByYear W19850217082019 @default.
• W1985021708 countsByYear W19850217082020 @default.
• W1985021708 countsByYear W19850217082021 @default.
• W1985021708 countsByYear W19850217082022 @default.
• W1985021708 countsByYear W19850217082023 @default.
• W1985021708 crossrefType "journal-article" @default.
• W1985021708 hasAuthorship W1985021708A5006496635 @default.
• W1985021708 hasAuthorship W1985021708A5019459457 @default.
• W1985021708 hasAuthorship W1985021708A5051207235 @default.
• W1985021708 hasAuthorship W1985021708A5051290396 @default.
• W1985021708 hasAuthorship W1985021708A5078263280 @default.
• W1985021708 hasBestOaLocation W19850217081 @default.
• W1985021708 hasConcept C126189478 @default.
• W1985021708 hasConcept C126322002 @default.
• W1985021708 hasConcept C134018914 @default.
• W1985021708 hasConcept C181199279 @default.
• W1985021708 hasConcept C185592680 @default.
• W1985021708 hasConcept C2775838275 @default.
• W1985021708 hasConcept C2776151105 @default.
• W1985021708 hasConcept C2776694085 @default.
• W1985021708 hasConcept C2778004101 @default.
• W1985021708 hasConcept C2778239845 @default.
• W1985021708 hasConcept C2778401633 @default.
• W1985021708 hasConcept C2778760513 @default.
• W1985021708 hasConcept C2780091579 @default.
• W1985021708 hasConcept C2780306776 @default.
• W1985021708 hasConcept C2781464872 @default.
• W1985021708 hasConcept C538909803 @default.
• W1985021708 hasConcept C55493867 @default.
• W1985021708 hasConcept C70899900 @default.
• W1985021708 hasConcept C71924100 @default.
• W1985021708 hasConcept C98274493 @default.
• W1985021708 hasConceptScore W1985021708C126189478 @default.
• W1985021708 hasConceptScore W1985021708C126322002 @default.
• W1985021708 hasConceptScore W1985021708C134018914 @default.
• W1985021708 hasConceptScore W1985021708C181199279 @default.
• W1985021708 hasConceptScore W1985021708C185592680 @default.
• W1985021708 hasConceptScore W1985021708C2775838275 @default.
• W1985021708 hasConceptScore W1985021708C2776151105 @default.

• next